SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Barclays Analyst Says Haleon's Transformation Is Too Slow

Barclays analyst Warren Ackerman says Haleon lacks sufficient portfolio resilience and that execution has been disappointing, despite its strong portfolio of brands including Advil and Panadol.

HLN

Related stories